Background image
Home Company Partnering

Seamless Integration at Any Stage 

Artis meets your program where it is — from early development through clinical GMP — working within your timeline, budget, and resources to reach the next milestone.

By uniting synthetic DNA, process and analytical development, GMP manufacturing, and CMC regulatory expertise on a single platform, we eliminate the handoffs and vendor fragmentation that slow programs down, preserving technical continuity from starting material to clinical supply.

We advance your program by meeting you where you are.

Engagement Models

Leveraging a proven platform, transferring your own proprietary process, or co-developing a novel therapy

Supporting programs at any stage

Joint Program Development

Joint Program Development

Combining our end-to-end capabilities with your innovation to accelerate progress from early development through clinical readiness, including process/analytical development, scale-up/scale-out, CMC regulatory support, IND enablement, cGMP manufacturing, and person-in-plant options.

Leverage Our Platforms

Leverage Our Platforms

Validated production platforms for preclinical, clinical, and commercial material to reach your next program milestone. Features include: multiple modalities (AAV, LVV, and CAR-T), Identical GMP and non-GMP systems, in-house analytics, and IND-readiness in only 9-12 months.

Transfer Your Process

Transfer Your Process

Hybrid, modular services, leverage our capabilities across development, manufacturing, and regulatory readiness, occuring in our Innovation Development Laboratory and/or GMP suites. GMP-ready protocols can be developed and executed by Artis, including raw material supply, product manufacture, fill-finish, and product shipment.